Latest
TipRanks Market update
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 317
- Sources here
- 16
- Companies here
- 28
Search results
Stored financial headlines
Active search
317 matching headlines
Ticker or company: NIMMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Elanco Investors Fail to Revive Sales Misrepresentation Suit
The Seventh Circuit Court of Appeals has ruled against Elanco Animal Health Inc. investors, preventing them from proceeding with claims that the company misrepresented its sales. The court upheld the dismissal of the proposed class action, stating that the investors did not adequately allege …
ELAN
main company
Sharemaestro market context
Price below Trend Line
52 weeks +32.2%
5 Must-Read Analyst Questions From Elanco’s Q2 Earnings Call
5 Must-Read Analyst Questions From Elanco's Q2 Earnings Call Elanco's results for the second quarter were positively received by the market, reflecting momentum across both its Pet Health and Farm Animal businesses. Management attributed growth to strong execution in the U.S. and international markets, …
ELAN
main company
Sharemaestro market context
Price below Trend Line
52 weeks +32.2%
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and ACADIA Pharmaceuticals (ACAD)
J.P. Morgan analyst Chris Schott maintained a Buy rating on Elanco Animal Health (ELAN) with a consensus price target of $31.11, representing a 35.3% upside. Needham analyst Ami Fadia assigned a Buy rating to ACADIA Pharmaceuticals (ACAD) with a price target of $41.00, implying …
ELAN
main company
Sharemaestro market context
Price below Trend Line
52 weeks +32.2%
Elanco Animal Health expands US screwworm response
Elanco Animal Health president and CEO Jeff Simmons discusses the company's efforts to combat the screwworm outbreak in the United States. The discussion took place on 'The Claman Countdown', highlighting Elanco's expanded response to the health issue.
ELAN
main company
Sharemaestro market context
Price below Trend Line
52 weeks +32.2%